808594

Salem, Galal M.D. — FEI 3009769207

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 4, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Riverside, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance